SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting17-09-2022
17-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the investor presentation, which we shall be uploading on our website after sending this letter to you.16-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201514-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 05, 2022 for Raksha Sudhir Valia05-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting03-09-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-08-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the following, with respect to 30th AGM of the Company held on August 29, 2022 at 3:00 p.m. IST by Video Conferencing. 1. Voting results as Annexure A 2. Scrutinizer's Consolidated Report as Annexure B All the resolutions set out in the Notice of the AGM were approved with the requisite majority.30-08-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate
Mr. Israel Makov (DIN: 05299764) has retired and ceased to be the Chairman and Director of the Company upon the conclusion of Annual General Meeting held on August 29, 2022. Mr. Gautam Doshi (DIN: 00004612) is re-appointed as an Independent Director of the Company for a second term of 5 years, from May 25, 2023 to May 24, 2028 Mr. Dilip Shanghvi (DIN: 00005588) is re-appointed as Managing Director of the Company for a further period of 5 years, from April 1, 2023 to March 31, 2028.29-08-2022
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 30th Annual General Meeting of Sun Pharmaceutical Industries Limited29-08-2022